vs

Side-by-side financial comparison of Playtika Holding Corp. (PLTK) and PERRIGO Co plc (PRGO). Click either name above to swap in a different company.

PERRIGO Co plc is the larger business by last-quarter revenue ($1.1B vs $678.8M, roughly 1.6× Playtika Holding Corp.). Playtika Holding Corp. runs the higher net margin — -45.6% vs -127.8%, a 82.2% gap on every dollar of revenue. On growth, Playtika Holding Corp. posted the faster year-over-year revenue change (4.4% vs -2.5%). Playtika Holding Corp. produced more free cash flow last quarter ($275.2M vs $148.6M). Over the past eight quarters, Playtika Holding Corp.'s revenue compounded faster (2.1% CAGR vs 1.3%).

Playtika Holding Corp. is an Israeli digital entertainment company specializing in the development and publication of mobile games. In 2021, Playtika had over 35 million monthly active users.

Perrigo Company plc is an American Irish-registered manufacturer of private label over-the-counter pharmaceuticals, and while 70% of Perrigo's net sales are from the U.S. healthcare system, Perrigo is legally headquartered in Ireland for tax purposes, which accounts for 0.60% of net sales. In 2013, Perrigo completed the sixth-largest US corporate tax inversion in history when it reregistered its tax status to Ireland to avoid U.S. corporate taxes. Perrigo maintains its corporate headquarters ...

PLTK vs PRGO — Head-to-Head

Bigger by revenue
PRGO
PRGO
1.6× larger
PRGO
$1.1B
$678.8M
PLTK
Growing faster (revenue YoY)
PLTK
PLTK
+6.9% gap
PLTK
4.4%
-2.5%
PRGO
Higher net margin
PLTK
PLTK
82.2% more per $
PLTK
-45.6%
-127.8%
PRGO
More free cash flow
PLTK
PLTK
$126.6M more FCF
PLTK
$275.2M
$148.6M
PRGO
Faster 2-yr revenue CAGR
PLTK
PLTK
Annualised
PLTK
2.1%
1.3%
PRGO

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
PLTK
PLTK
PRGO
PRGO
Revenue
$678.8M
$1.1B
Net Profit
$-309.3M
$-1.4B
Gross Margin
72.5%
32.6%
Operating Margin
-41.4%
-116.0%
Net Margin
-45.6%
-127.8%
Revenue YoY
4.4%
-2.5%
Net Profit YoY
-1752.1%
-3093.9%
EPS (diluted)
$-0.83
$-10.23

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
PLTK
PLTK
PRGO
PRGO
Q4 25
$678.8M
$1.1B
Q3 25
$674.6M
$1.0B
Q2 25
$696.0M
$1.1B
Q1 25
$706.0M
$1.0B
Q4 24
$650.3M
$1.1B
Q3 24
$620.8M
$1.1B
Q2 24
$627.0M
$1.1B
Q1 24
$651.2M
$1.1B
Net Profit
PLTK
PLTK
PRGO
PRGO
Q4 25
$-309.3M
$-1.4B
Q3 25
$39.1M
$7.5M
Q2 25
$33.2M
$-8.4M
Q1 25
$30.6M
$-6.4M
Q4 24
$-16.7M
$-44.4M
Q3 24
$39.3M
$-21.0M
Q2 24
$86.6M
$-108.4M
Q1 24
$53.0M
$2.0M
Gross Margin
PLTK
PLTK
PRGO
PRGO
Q4 25
72.5%
32.6%
Q3 25
73.6%
36.1%
Q2 25
71.9%
34.4%
Q1 25
72.0%
37.6%
Q4 24
72.5%
33.9%
Q3 24
72.9%
37.2%
Q2 24
73.2%
37.0%
Q1 24
72.8%
33.1%
Operating Margin
PLTK
PLTK
PRGO
PRGO
Q4 25
-41.4%
-116.0%
Q3 25
14.6%
7.0%
Q2 25
15.8%
4.3%
Q1 25
9.6%
4.5%
Q4 24
8.5%
10.0%
Q3 24
15.7%
7.4%
Q2 24
22.4%
-2.5%
Q1 24
15.1%
-5.1%
Net Margin
PLTK
PLTK
PRGO
PRGO
Q4 25
-45.6%
-127.8%
Q3 25
5.8%
0.7%
Q2 25
4.8%
-0.8%
Q1 25
4.3%
-0.6%
Q4 24
-2.6%
-3.9%
Q3 24
6.3%
-1.9%
Q2 24
13.8%
-10.2%
Q1 24
8.1%
0.2%
EPS (diluted)
PLTK
PLTK
PRGO
PRGO
Q4 25
$-0.83
$-10.23
Q3 25
$0.11
$0.05
Q2 25
$0.09
$-0.06
Q1 25
$0.08
$-0.05
Q4 24
$-0.04
$-0.32
Q3 24
$0.11
$-0.15
Q2 24
$0.23
$-0.79
Q1 24
$0.14
$0.01

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
PLTK
PLTK
PRGO
PRGO
Cash + ST InvestmentsLiquidity on hand
$684.2M
Total DebtLower is stronger
$2.4B
Stockholders' EquityBook value
$-411.4M
$2.9B
Total Assets
$3.7B
$8.5B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
PLTK
PLTK
PRGO
PRGO
Q4 25
$684.2M
Q3 25
$587.9M
$432.1M
Q2 25
$500.9M
$454.2M
Q1 25
$434.8M
$409.9M
Q4 24
$565.8M
$558.8M
Q3 24
$1.1B
$1.5B
Q2 24
$710.3M
$542.8M
Q1 24
$1.0B
$658.5M
Total Debt
PLTK
PLTK
PRGO
PRGO
Q4 25
$2.4B
Q3 25
$2.4B
Q2 25
$2.4B
Q1 25
$2.4B
Q4 24
$2.4B
Q3 24
$2.4B
Q2 24
$2.4B
Q1 24
$2.4B
Stockholders' Equity
PLTK
PLTK
PRGO
PRGO
Q4 25
$-411.4M
$2.9B
Q3 25
$-74.8M
$4.4B
Q2 25
$-87.8M
$4.5B
Q1 25
$-117.2M
$4.4B
Q4 24
$-131.1M
$4.3B
Q3 24
$-98.0M
$4.6B
Q2 24
$-112.9M
$4.5B
Q1 24
$-180.4M
$4.7B
Total Assets
PLTK
PLTK
PRGO
PRGO
Q4 25
$3.7B
$8.5B
Q3 25
$3.7B
$10.1B
Q2 25
$3.6B
$10.1B
Q1 25
$3.6B
$9.8B
Q4 24
$3.6B
$9.6B
Q3 24
$3.2B
$11.2B
Q2 24
$3.2B
$10.4B
Q1 24
$3.1B
$10.6B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
PLTK
PLTK
PRGO
PRGO
Operating Cash FlowLast quarter
$285.9M
$175.4M
Free Cash FlowOCF − Capex
$275.2M
$148.6M
FCF MarginFCF / Revenue
40.5%
13.4%
Capex IntensityCapex / Revenue
1.6%
2.4%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$531.4M
$145.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
PLTK
PLTK
PRGO
PRGO
Q4 25
$285.9M
$175.4M
Q3 25
$116.9M
$51.7M
Q2 25
$146.1M
$75.9M
Q1 25
$18.8M
$-64.5M
Q4 24
$153.1M
$312.6M
Q3 24
$156.9M
$42.2M
Q2 24
$150.5M
$9.5M
Q1 24
$29.6M
$-1.4M
Free Cash Flow
PLTK
PLTK
PRGO
PRGO
Q4 25
$275.2M
$148.6M
Q3 25
$106.5M
$29.8M
Q2 25
$141.3M
$56.7M
Q1 25
$8.4M
$-90.0M
Q4 24
$140.3M
$274.9M
Q3 24
$152.1M
$15.1M
Q2 24
$141.2M
$-18.9M
Q1 24
$15.6M
$-26.5M
FCF Margin
PLTK
PLTK
PRGO
PRGO
Q4 25
40.5%
13.4%
Q3 25
15.8%
2.9%
Q2 25
20.3%
5.4%
Q1 25
1.2%
-8.6%
Q4 24
21.6%
24.2%
Q3 24
24.5%
1.4%
Q2 24
22.5%
-1.8%
Q1 24
2.4%
-2.4%
Capex Intensity
PLTK
PLTK
PRGO
PRGO
Q4 25
1.6%
2.4%
Q3 25
1.5%
2.1%
Q2 25
0.7%
1.8%
Q1 25
1.5%
2.4%
Q4 24
2.0%
3.3%
Q3 24
0.8%
2.5%
Q2 24
1.5%
2.7%
Q1 24
2.1%
2.3%
Cash Conversion
PLTK
PLTK
PRGO
PRGO
Q4 25
Q3 25
2.99×
6.89×
Q2 25
4.40×
Q1 25
0.61×
Q4 24
Q3 24
3.99×
Q2 24
1.74×
Q1 24
0.56×
-0.70×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

PLTK
PLTK

Third Party Platform$428.7M63%
Other$158.8M23%
Asia Pacific$52.7M8%
Other Geographic Location$38.6M6%

PRGO
PRGO

Consumer Self Care Americas$697.0M63%
Digestive Health$123.9M11%
Nutrition$108.3M10%
Healthy Lifestyle$94.8M9%
Pain And Sleep Aids$87.1M8%

Related Comparisons